| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
55,416 |
50,598 |
$10.63M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
33,974 |
31,333 |
$2.69M |
| 80053 |
Comprehensive metabolic panel |
33,648 |
26,627 |
$2.36M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
29,492 |
26,955 |
$1.98M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
82,720 |
70,319 |
$1.98M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,967 |
23,732 |
$1.67M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,488 |
6,323 |
$1.62M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,617 |
1,590 |
$1.58M |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
915 |
472 |
$1.43M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
18,065 |
6,355 |
$1.34M |
| J0485 |
Injection, belatacept, 1 mg |
1,774 |
1,620 |
$1.25M |
| 74183 |
|
2,294 |
2,250 |
$1.25M |
| 0710 |
|
3,820 |
3,540 |
$1.16M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
55,805 |
48,540 |
$1.11M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
1,134 |
626 |
$1.03M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,765 |
9,749 |
$864K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
35,574 |
29,890 |
$846K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,084 |
2,334 |
$800K |
| 87496 |
|
2,182 |
1,594 |
$788K |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,623 |
5,417 |
$755K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,562 |
6,972 |
$739K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,003 |
2,637 |
$690K |
| J3262 |
Injection, tocilizumab, 1 mg |
634 |
431 |
$656K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,661 |
1,623 |
$652K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,026 |
3,630 |
$631K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
18,917 |
5,693 |
$623K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,403 |
10,577 |
$617K |
| 83735 |
|
17,461 |
12,396 |
$597K |
| 71250 |
|
4,995 |
4,932 |
$585K |
| 94375 |
|
3,977 |
3,342 |
$561K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
17,364 |
15,920 |
$525K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
107,399 |
66,190 |
$514K |
| 93970 |
|
16,951 |
15,091 |
$507K |
| 86832 |
|
3,213 |
3,080 |
$498K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,631 |
11,539 |
$498K |
| 86833 |
|
3,268 |
3,095 |
$490K |
| 99233 |
Prolong inpt eval add15 m |
12,869 |
4,440 |
$478K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,431 |
3,335 |
$462K |
| 0270 |
|
5,323 |
3,480 |
$441K |
| 71046 |
Radiologic examination, chest; 2 views |
8,684 |
8,263 |
$440K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,979 |
1,937 |
$433K |
| 86900 |
|
5,414 |
4,429 |
$428K |
| J3490 |
Unclassified drugs |
14,076 |
8,484 |
$424K |
| G0378 |
Hospital observation service, per hour |
2,229 |
1,426 |
$410K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,300 |
2,246 |
$406K |
| 93454 |
|
1,069 |
1,009 |
$405K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,820 |
11,351 |
$398K |
| 87497 |
|
1,547 |
1,301 |
$386K |
| 84100 |
|
13,877 |
9,892 |
$386K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,548 |
6,243 |
$380K |
| 71045 |
Radiologic examination, chest; single view |
12,760 |
11,956 |
$372K |
| 86850 |
|
4,810 |
3,851 |
$367K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,983 |
1,929 |
$352K |
| 0250 |
|
13,527 |
8,925 |
$351K |
| 80197 |
|
12,292 |
7,928 |
$303K |
| 86975 |
|
4,490 |
3,455 |
$303K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,838 |
1,803 |
$295K |
| 0761 |
|
3,135 |
2,675 |
$291K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
1,365 |
1,332 |
$271K |
| Q3014 |
Telehealth originating site facility fee |
14,714 |
13,303 |
$268K |
| 87799 |
|
1,606 |
1,330 |
$258K |
| 99215 |
Prolong outpt/office vis |
6,469 |
5,427 |
$257K |
| 86901 |
|
5,364 |
4,324 |
$248K |
| 0510 |
|
14,101 |
11,887 |
$237K |
| 94726 |
|
1,629 |
1,436 |
$233K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12,933 |
11,907 |
$231K |
| 80076 |
|
19,025 |
16,305 |
$229K |
| 99223 |
Prolong inpt eval add15 m |
3,318 |
3,117 |
$224K |
| 81001 |
|
27,129 |
23,206 |
$217K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,747 |
1,415 |
$215K |
| 0760 |
|
6,788 |
5,679 |
$205K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,557 |
1,541 |
$200K |
| 0272 |
|
4,230 |
3,897 |
$199K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,166 |
1,927 |
$185K |
| Z7500 |
|
5,157 |
4,287 |
$175K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,266 |
4,868 |
$175K |
| 75574 |
|
1,912 |
1,886 |
$171K |
| 80061 |
Lipid panel |
8,736 |
8,560 |
$166K |
| 93505 |
|
118 |
95 |
$163K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,805 |
1,670 |
$161K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,807 |
3,619 |
$158K |
| 96376 |
|
2,763 |
2,163 |
$156K |
| 72197 |
|
801 |
791 |
$156K |
| 99222 |
Initial hospital care, per day, moderate complexity |
2,986 |
2,740 |
$151K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,861 |
4,587 |
$148K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,540 |
3,828 |
$147K |
| J0897 |
Injection, denosumab, 1 mg |
291 |
285 |
$145K |
| 85610 |
|
10,455 |
9,329 |
$144K |
| 96415 |
|
1,632 |
1,354 |
$143K |
| 93325 |
|
5,386 |
4,366 |
$142K |
| 87088 |
|
7,521 |
6,652 |
$141K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,005 |
6,501 |
$136K |
| 93971 |
|
4,191 |
3,637 |
$135K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,250 |
2,216 |
$133K |
| 82784 |
|
2,582 |
1,539 |
$132K |
| 83880 |
|
7,890 |
7,240 |
$132K |
| 83615 |
|
3,453 |
2,447 |
$130K |
| C1769 |
Guide wire |
862 |
815 |
$119K |
| 93880 |
|
2,603 |
2,284 |
$117K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,564 |
1,842 |
$117K |
| 0370 |
|
1,853 |
1,795 |
$117K |
| 74174 |
|
410 |
406 |
$114K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,131 |
1,940 |
$113K |
| 94729 |
|
1,847 |
1,638 |
$112K |
| 87040 |
|
3,279 |
2,588 |
$109K |
| 38222 |
|
161 |
143 |
$107K |
| 84484 |
|
11,270 |
9,455 |
$101K |
| 88185 |
|
77 |
51 |
$96K |
| 78812 |
|
307 |
295 |
$93K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,041 |
2,752 |
$89K |
| J2704 |
Injection, propofol, 10 mg |
3,390 |
2,944 |
$89K |
| A9581 |
Injection, gadoxetate disodium, 1 ml |
925 |
825 |
$88K |
| J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg |
32 |
17 |
$87K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,310 |
4,504 |
$87K |
| 82803 |
|
467 |
403 |
$86K |
| 72141 |
|
517 |
513 |
$84K |
| 83690 |
|
10,191 |
9,499 |
$83K |
| 99199 |
Unlisted special service, procedure or report |
3,070 |
2,681 |
$80K |
| 93312 |
|
1,167 |
1,016 |
$79K |
| 88341 |
|
380 |
257 |
$79K |
| 78492 |
|
156 |
150 |
$79K |
| 93975 |
|
656 |
601 |
$77K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
3,334 |
2,778 |
$75K |
| 85730 |
|
6,925 |
6,539 |
$75K |
| 73502 |
|
912 |
885 |
$74K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
3,791 |
1,891 |
$72K |
| 93308 |
|
4,198 |
3,377 |
$70K |
| 82565 |
|
4,575 |
4,477 |
$68K |
| 99221 |
|
1,913 |
1,750 |
$68K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
6,272 |
2,895 |
$66K |
| 94200 |
|
1,447 |
1,300 |
$64K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,781 |
1,746 |
$63K |
| J9310 |
Injection, rituximab, 100 mg |
29 |
24 |
$63K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,364 |
1,302 |
$62K |
| 83605 |
|
4,129 |
3,769 |
$62K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,194 |
1,086 |
$62K |
| 99205 |
Prolong outpt/office vis |
1,481 |
1,456 |
$62K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
390 |
353 |
$59K |
| 84703 |
|
5,928 |
5,537 |
$58K |
| 88342 |
|
688 |
580 |
$58K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,140 |
1,107 |
$56K |
| 77080 |
|
1,249 |
1,232 |
$55K |
| Z7502 |
|
1,447 |
1,403 |
$54K |
| Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg |
134 |
73 |
$52K |
| 36556 |
|
932 |
833 |
$51K |
| 84550 |
|
3,778 |
3,503 |
$51K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,865 |
2,073 |
$51K |
| A4649 |
Surgical supply; miscellaneous |
121 |
73 |
$50K |
| 76830 |
Ultrasound, transvaginal |
1,270 |
1,211 |
$49K |
| 92928 |
|
186 |
145 |
$49K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,031 |
7,880 |
$49K |
| 76937 |
|
1,515 |
1,370 |
$48K |
| 77066 |
Tomosynthesis, mammo |
1,331 |
1,323 |
$48K |
| 82378 |
|
2,418 |
2,281 |
$47K |
| 82728 |
|
3,538 |
3,434 |
$47K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,758 |
5,878 |
$46K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,462 |
1,430 |
$46K |
| 73562 |
|
1,872 |
1,563 |
$46K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,936 |
3,885 |
$45K |
| 72131 |
|
416 |
415 |
$44K |
| 87186 |
|
2,640 |
2,353 |
$44K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,203 |
1,423 |
$43K |
| 91065 |
|
363 |
264 |
$43K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
431 |
414 |
$42K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,787 |
4,713 |
$42K |
| 93922 |
|
2,401 |
2,210 |
$39K |
| 31624 |
|
297 |
265 |
$38K |
| 73030 |
|
1,520 |
1,376 |
$37K |
| 87340 |
|
1,199 |
1,154 |
$37K |
| 82550 |
|
1,931 |
1,795 |
$36K |
| 73610 |
|
1,478 |
1,320 |
$36K |
| 94010 |
|
245 |
202 |
$36K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
238 |
232 |
$36K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
257 |
246 |
$35K |
| 93451 |
|
31 |
28 |
$35K |
| 94618 |
|
472 |
410 |
$35K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
913 |
864 |
$34K |
| 77334 |
|
339 |
266 |
$33K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,842 |
2,478 |
$33K |
| 93321 |
|
5,301 |
4,229 |
$32K |
| 92978 |
|
72 |
64 |
$32K |
| 82570 |
|
3,874 |
3,442 |
$32K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,998 |
2,779 |
$32K |
| 87070 |
|
1,611 |
1,498 |
$31K |
| 86803 |
|
1,645 |
1,617 |
$31K |
| 49083 |
|
363 |
217 |
$31K |
| 0301 |
|
935 |
652 |
$30K |
| 73630 |
|
1,428 |
1,251 |
$30K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,768 |
2,109 |
$30K |
| 99292 |
|
798 |
478 |
$30K |
| 88184 |
|
159 |
129 |
$29K |
| 85027 |
|
5,106 |
4,581 |
$29K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
506 |
438 |
$29K |
| 86480 |
|
493 |
481 |
$28K |
| 76642 |
|
1,310 |
1,154 |
$28K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,466 |
1,403 |
$28K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,448 |
1,385 |
$28K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,248 |
7,157 |
$27K |
| 81370 |
|
29 |
25 |
$27K |
| 0002A |
|
771 |
769 |
$27K |
| 32555 |
|
697 |
514 |
$27K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
584 |
562 |
$27K |
| 84156 |
|
2,553 |
2,330 |
$27K |
| 70496 |
|
102 |
102 |
$26K |
| 31623 |
|
14 |
13 |
$26K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
168 |
142 |
$25K |
| 72100 |
|
962 |
932 |
$25K |
| 70491 |
|
149 |
145 |
$25K |
| 43264 |
|
66 |
62 |
$25K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,372 |
2,189 |
$24K |
| 86140 |
|
4,740 |
4,526 |
$24K |
| 93320 |
|
279 |
240 |
$24K |
| 20610 |
|
1,199 |
1,080 |
$24K |
| 87077 |
|
5,201 |
4,637 |
$24K |
| 0001A |
|
687 |
686 |
$24K |
| 86592 |
|
471 |
449 |
$24K |
| 93017 |
|
745 |
721 |
$23K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
982 |
705 |
$22K |
| 72170 |
|
664 |
649 |
$22K |
| 70486 |
|
253 |
245 |
$22K |
| 87522 |
Neg quan hep c or qual rna |
191 |
163 |
$22K |
| 88307 |
|
143 |
122 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,917 |
2,194 |
$22K |
| 93923 |
|
716 |
600 |
$21K |
| 85379 |
|
2,027 |
1,974 |
$21K |
| 0949 |
|
582 |
432 |
$21K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,422 |
1,395 |
$21K |
| 86923 |
|
192 |
177 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
5,486 |
4,215 |
$20K |
| 0160 |
|
453 |
279 |
$20K |
| Z9726 |
|
440 |
436 |
$19K |
| 73130 |
|
920 |
757 |
$19K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,502 |
3,977 |
$19K |
| 90715 |
|
794 |
775 |
$19K |
| J2785 |
Injection, regadenoson, 0.1 mg |
560 |
546 |
$18K |
| 93296 |
|
842 |
838 |
$18K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
488 |
458 |
$18K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,842 |
2,475 |
$18K |
| 88350 |
|
85 |
54 |
$18K |
| 83550 |
|
4,265 |
4,167 |
$18K |
| 83540 |
|
4,604 |
4,486 |
$18K |
| 76770 |
|
353 |
344 |
$17K |
| 82962 |
|
929 |
663 |
$17K |
| 86930 |
|
71 |
57 |
$17K |
| 87517 |
|
207 |
202 |
$17K |
| 96367 |
|
445 |
342 |
$16K |
| 70498 |
|
72 |
71 |
$16K |
| 77065 |
Tomosynthesis, mammo |
557 |
557 |
$15K |
| J9312 |
Injection, rituximab, 10 mg |
14 |
12 |
$15K |
| 83883 |
|
546 |
376 |
$15K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,981 |
2,413 |
$15K |
| 99254 |
|
206 |
168 |
$15K |
| 82607 |
|
2,539 |
2,501 |
$15K |
| 0305 |
|
659 |
551 |
$14K |
| 73110 |
|
549 |
464 |
$14K |
| 87205 |
|
1,576 |
1,471 |
$14K |
| 93458 |
|
50 |
46 |
$14K |
| 96116 |
|
336 |
294 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,802 |
3,293 |
$14K |
| 97162 |
|
508 |
505 |
$14K |
| 85652 |
|
4,323 |
4,165 |
$13K |
| 93925 |
|
830 |
732 |
$13K |
| 99070 |
|
40 |
26 |
$13K |
| 87536 |
|
167 |
163 |
$13K |
| 86300 |
|
1,583 |
1,425 |
$13K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
873 |
859 |
$13K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
489 |
380 |
$13K |
| 74181 |
|
12 |
12 |
$13K |
| 87400 |
|
1,052 |
920 |
$12K |
| 73590 |
|
738 |
641 |
$12K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
308 |
297 |
$12K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,106 |
1,103 |
$12K |
| 76942 |
|
155 |
151 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,924 |
1,743 |
$11K |
| 99152 |
|
438 |
408 |
$11K |
| 77300 |
|
76 |
68 |
$10K |
| 83970 |
|
1,116 |
1,096 |
$10K |
| 84702 |
|
784 |
678 |
$10K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,003 |
823 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
654 |
554 |
$10K |
| 76376 |
|
514 |
468 |
$9K |
| 0306 |
|
321 |
299 |
$9K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
15 |
12 |
$9K |
| 0511 |
|
1,453 |
1,360 |
$9K |
| 80306 |
|
909 |
878 |
$8K |
| 99253 |
|
99 |
86 |
$8K |
| 88313 |
|
72 |
51 |
$8K |
| 86704 |
|
464 |
455 |
$8K |
| 0271 |
|
1,400 |
1,313 |
$8K |
| 36600 |
|
78 |
72 |
$8K |
| 86706 |
|
503 |
496 |
$8K |
| 82746 |
|
1,337 |
1,320 |
$7K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
916 |
560 |
$7K |
| 88346 |
|
63 |
56 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,135 |
721 |
$7K |
| 87081 |
|
1,246 |
1,096 |
$7K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
360 |
285 |
$7K |
| J2060 |
Injection, lorazepam, 2 mg |
1,125 |
978 |
$6K |
| 0004A |
|
154 |
154 |
$6K |
| 76536 |
|
249 |
240 |
$6K |
| 95720 |
|
75 |
36 |
$6K |
| 93990 |
|
242 |
188 |
$6K |
| 81376 |
|
18 |
12 |
$6K |
| 0762 |
|
244 |
212 |
$6K |
| 81025 |
|
384 |
368 |
$6K |
| 73560 |
|
485 |
419 |
$6K |
| 99443 |
|
97 |
86 |
$6K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
931 |
874 |
$5K |
| 86039 |
|
623 |
615 |
$5K |
| 72040 |
|
178 |
173 |
$5K |
| 93926 |
|
174 |
138 |
$5K |
| 73221 |
|
67 |
64 |
$5K |
| 73700 |
|
58 |
55 |
$5K |
| 84165 |
|
84 |
77 |
$5K |
| Q4051 |
Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) |
18 |
13 |
$5K |
| 0324 |
|
267 |
260 |
$5K |
| 73564 |
|
181 |
163 |
$5K |
| 96130 |
|
158 |
157 |
$5K |
| 77290 |
|
41 |
39 |
$4K |
| 84439 |
|
1,714 |
1,673 |
$4K |
| 31500 |
|
101 |
92 |
$4K |
| 84153 |
|
854 |
842 |
$4K |
| 99255 |
|
43 |
38 |
$4K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
500 |
398 |
$4K |
| 96417 |
|
358 |
226 |
$4K |
| 76604 |
|
256 |
223 |
$4K |
| 0637 |
|
837 |
621 |
$4K |
| 97161 |
|
122 |
121 |
$4K |
| 95951 |
|
43 |
14 |
$4K |
| 72110 |
|
298 |
294 |
$4K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
88 |
81 |
$4K |
| 86830 |
|
56 |
54 |
$4K |
| 0300 |
|
388 |
326 |
$4K |
| 86780 |
|
461 |
429 |
$4K |
| 36430 |
|
29 |
25 |
$4K |
| 86831 |
|
56 |
54 |
$4K |
| 0403 |
|
25 |
25 |
$4K |
| 93319 |
|
246 |
201 |
$3K |
| 93798 |
|
43 |
12 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
480 |
479 |
$3K |
| 73552 |
|
142 |
131 |
$3K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
326 |
302 |
$3K |
| 86352 |
|
98 |
95 |
$3K |
| 0031A |
|
77 |
77 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,055 |
909 |
$3K |
| 77263 |
|
79 |
78 |
$3K |
| 80320 |
|
345 |
310 |
$3K |
| 74160 |
|
14 |
13 |
$3K |
| 75572 |
|
12 |
12 |
$3K |
| 90656 |
|
178 |
142 |
$3K |
| 62270 |
|
28 |
27 |
$3K |
| 93280 |
|
198 |
170 |
$3K |
| 89051 |
|
579 |
531 |
$3K |
| 85007 |
|
513 |
481 |
$3K |
| 73080 |
|
102 |
91 |
$2K |
| 86334 |
|
12 |
12 |
$2K |
| 82105 |
|
226 |
215 |
$2K |
| 87505 |
|
87 |
62 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
315 |
303 |
$2K |
| Z9725 |
|
54 |
52 |
$2K |
| 31628 |
|
26 |
25 |
$2K |
| 82330 |
|
235 |
229 |
$2K |
| 82043 |
|
1,352 |
1,341 |
$2K |
| 88188 |
|
30 |
29 |
$2K |
| 86235 |
|
449 |
242 |
$2K |
| 84436 |
|
763 |
755 |
$2K |
| 0401 |
|
398 |
398 |
$2K |
| J7507 |
Tacrolimus, immediate release, oral, 1 mg |
191 |
181 |
$2K |
| 93978 |
|
34 |
26 |
$2K |
| 85347 |
|
47 |
37 |
$2K |
| 83521 |
|
737 |
685 |
$2K |
| 85014 |
|
194 |
189 |
$2K |
| 84132 |
|
126 |
123 |
$2K |
| 0352 |
|
25 |
24 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
85 |
85 |
$2K |
| 82375 |
|
17 |
16 |
$2K |
| J7999 |
Compounded drug, not otherwise classified |
28 |
27 |
$2K |
| 90686 |
|
113 |
111 |
$2K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
14 |
13 |
$2K |
| 96132 |
|
42 |
37 |
$2K |
| 99252 |
|
35 |
26 |
$2K |
| 91200 |
|
42 |
28 |
$2K |
| 36620 |
|
96 |
85 |
$2K |
| 93355 |
|
52 |
52 |
$2K |
| 87116 |
|
18 |
15 |
$2K |
| 85651 |
|
450 |
432 |
$2K |
| 93247 |
|
68 |
68 |
$1K |
| 96131 |
|
106 |
105 |
$1K |
| 78306 |
|
28 |
28 |
$1K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
226 |
214 |
$1K |
| 87420 |
|
67 |
64 |
$1K |
| 0298T |
|
122 |
121 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
153 |
128 |
$1K |
| 80158 |
|
48 |
38 |
$1K |
| 87102 |
|
48 |
44 |
$1K |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
48 |
45 |
$1K |
| 92611 |
|
59 |
57 |
$1K |
| 97010 |
|
720 |
385 |
$1K |
| 85046 |
|
340 |
312 |
$1K |
| 84481 |
|
281 |
271 |
$1K |
| 0003A |
|
31 |
31 |
$1K |
| 0258 |
|
76 |
71 |
$1K |
| 86790 |
|
150 |
147 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
47 |
41 |
$1K |
| 93294 |
|
115 |
115 |
$1K |
| 77014 |
|
111 |
12 |
$1K |
| 0054A |
|
28 |
28 |
$1K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
233 |
157 |
$1K |
| 86769 |
|
26 |
15 |
$1K |
| 82150 |
|
194 |
181 |
$1K |
| 72070 |
|
18 |
18 |
$1K |
| 82947 |
|
132 |
129 |
$1K |
| Q0511 |
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period |
297 |
289 |
$1K |
| 84520 |
|
146 |
143 |
$989.64 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
28 |
26 |
$986.59 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
349 |
314 |
$955.45 |
| 74018 |
|
57 |
56 |
$939.31 |
| 99442 |
|
25 |
25 |
$868.55 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
427 |
427 |
$859.17 |
| 86431 |
|
237 |
235 |
$856.51 |
| 72158 |
|
12 |
12 |
$846.53 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
198 |
194 |
$832.31 |
| 74230 |
|
60 |
58 |
$825.13 |
| 86359 |
|
18 |
16 |
$797.72 |
| 97116 |
|
100 |
68 |
$791.31 |
| 12001 |
|
15 |
14 |
$776.99 |
| 87210 |
|
74 |
69 |
$749.10 |
| 84479 |
|
160 |
159 |
$744.27 |
| 72082 |
|
85 |
84 |
$727.80 |
| J1756 |
Injection, iron sucrose, 1 mg |
31 |
12 |
$723.42 |
| 81003 |
|
255 |
185 |
$722.28 |
| Q0512 |
Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period |
288 |
253 |
$701.96 |
| 12011 |
|
13 |
12 |
$682.35 |
| 0071A |
|
17 |
17 |
$680.00 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
54 |
42 |
$645.35 |
| 0072A |
|
16 |
16 |
$640.00 |
| 72128 |
|
26 |
26 |
$637.02 |
| 93246 |
|
51 |
51 |
$602.48 |
| 0730 |
|
129 |
126 |
$582.67 |
| 93248 |
|
126 |
125 |
$524.01 |
| 74328 |
|
41 |
40 |
$487.07 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
63 |
54 |
$478.89 |
| 0320 |
|
32 |
30 |
$470.37 |
| 0360 |
|
222 |
125 |
$456.17 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
123 |
108 |
$433.77 |
| 74022 |
|
41 |
40 |
$431.23 |
| 80047 |
|
27 |
26 |
$428.94 |
| 87480 |
|
182 |
175 |
$428.64 |
| 87510 |
|
182 |
175 |
$428.64 |
| 93979 |
|
26 |
26 |
$425.07 |
| 93279 |
|
32 |
25 |
$385.79 |
| 87660 |
|
182 |
175 |
$350.37 |
| 82232 |
|
321 |
311 |
$339.33 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
125 |
124 |
$321.81 |
| J7517 |
Mycophenolate mofetil, oral, 250 mg |
40 |
38 |
$318.90 |
| 87015 |
|
39 |
30 |
$287.28 |
| 75571 |
|
24 |
24 |
$250.66 |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
79 |
49 |
$248.19 |
| 76377 |
|
124 |
118 |
$248.13 |
| 86160 |
|
391 |
205 |
$244.03 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
12 |
12 |
$242.98 |
| 76801 |
|
15 |
12 |
$239.20 |
| 86301 |
|
152 |
140 |
$233.81 |
| 84295 |
|
28 |
28 |
$225.74 |
| 86360 |
|
15 |
15 |
$205.70 |
| 82652 |
|
13 |
13 |
$200.72 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
155 |
155 |
$199.94 |
| 96121 |
|
16 |
12 |
$196.44 |
| 77280 |
|
14 |
12 |
$195.49 |
| 82310 |
|
219 |
217 |
$194.56 |
| 86787 |
|
13 |
13 |
$187.88 |
| 82977 |
|
12 |
12 |
$187.48 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
15 |
15 |
$185.40 |
| 73521 |
|
43 |
43 |
$175.39 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
39 |
39 |
$175.09 |
| 97166 |
|
17 |
16 |
$166.29 |
| 82533 |
|
146 |
130 |
$165.78 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
44 |
41 |
$161.68 |
| 87206 |
|
17 |
14 |
$159.76 |
| 86225 |
|
272 |
258 |
$158.37 |
| 73090 |
|
16 |
12 |
$146.07 |
| J1630 |
Injection, haloperidol, up to 5 mg |
35 |
27 |
$144.68 |
| 94060 |
|
13 |
12 |
$144.12 |
| 0780 |
|
220 |
206 |
$140.30 |
| 77081 |
|
43 |
43 |
$136.37 |
| 73060 |
|
15 |
12 |
$135.05 |
| G0008 |
Administration of influenza virus vaccine |
27 |
27 |
$134.39 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
335 |
325 |
$128.57 |
| 0309 |
|
161 |
152 |
$123.95 |
| 88142 |
|
148 |
147 |
$115.40 |
| 97802 |
|
13 |
13 |
$97.12 |
| 86376 |
|
123 |
123 |
$91.36 |
| J2305 |
Injection, nitroglycerin, 5 mg |
103 |
103 |
$85.14 |
| 80349 |
|
56 |
51 |
$75.74 |
| 72050 |
|
25 |
25 |
$71.07 |
| 84402 |
|
43 |
39 |
$69.74 |
| 86200 |
|
128 |
127 |
$59.84 |
| 0636 |
|
45 |
23 |
$51.24 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
29 |
26 |
$50.87 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
43 |
18 |
$50.85 |
| 83721 |
|
197 |
197 |
$49.04 |
| 84403 |
|
204 |
193 |
$48.56 |
| 83010 |
|
85 |
81 |
$47.77 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
15 |
12 |
$37.30 |
| 86141 |
|
48 |
48 |
$34.81 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
44 |
44 |
$34.64 |
| 82274 |
|
174 |
127 |
$32.97 |
| J3480 |
Injection, potassium chloride, per 2 meq |
14 |
12 |
$31.89 |
| 80324 |
|
40 |
36 |
$25.07 |
| 80359 |
|
40 |
36 |
$25.03 |
| 84300 |
|
44 |
42 |
$24.49 |
| 82435 |
|
15 |
15 |
$20.57 |
| 84154 |
|
12 |
12 |
$18.02 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
165 |
161 |
$17.94 |
| 82374 |
|
14 |
14 |
$14.73 |
| 83921 |
|
26 |
26 |
$13.24 |
| 83951 |
|
39 |
39 |
$12.05 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
78 |
74 |
$10.42 |
| 82107 |
|
25 |
25 |
$9.93 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
39 |
39 |
$0.20 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
54 |
29 |
$0.00 |
| 0307 |
|
13 |
13 |
$0.00 |
| 0120 |
|
12 |
12 |
$0.00 |
| 0302 |
|
174 |
65 |
$0.00 |
| J7643 |
Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
13 |
13 |
$0.00 |
| 86765 |
|
12 |
12 |
$0.00 |
| 86709 |
|
14 |
12 |
$0.00 |
| 74178 |
|
12 |
12 |
$0.00 |